Myri BC7500 instructions for use:
Using Myriad's original high, medium, and low 3 concentration levels of quality control products, indoor quality control is performed once a day for at least 20 consecutive days of testing, and the coefficient of variation of the in-control data is calculated after eliminating the out-of-control data, and the evaluation of the day-to-day precision is performed.
Myriad Automatic Blood Cell Analyzer BC-7500 CRP provides a new blood analysis solution for secondary and tertiary hospitals.
BC-7500 CRP adopts SF-Cube 2.0 three-dimensional fluorescence analysis platform, through 360-degree rotation and three-dimensional scatter plot segmentation algorithms, it simultaneously performs optimal analysis of the particle population in three dimensions, and accurately outputs each blood parameter and abnormality alarms, with better detection performance for abnormal white lineage, red lineage and platelets.
Peripheral blood sampling is a large part of many maternal and child hospitals, and studies have shown that immediate testing of peripheral blood specimens after collection can cause a false reduction in platelet results for patients with true low PLT due to certain diseases.
With the obvious risk of platelet misreporting, the BC-7500 CRP automates routine blood testing with a dedicated peripheral blood tube rack and puncturable peripheral blood tubes that do not require removal of the cap, peripheral blood bionic standard mixing technology, and customized re-testing rules that do not require differentiation between venous blood and peripheral blood testing methods.
Myri BC-7500 Launch Event:
Myri BC-7500 CRP Online Launch Event was held grandly. More than 20,000 people witnessed this new product launch online, and more than twenty offline branch offices watched it synchronously.
The conference took 48 minutes, and used virtual studio and AR technology to concisely and efficiently present the BC-7500 CRP's research and development, technological innovation, and product highlights on the screen. The conference was attended by a number of heavyweights from China's laboratory medicine industry as well as senior leaders from Myriad Healthcare.